Alessio Nocentini

Sesto Fiorentino, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 291 publications

Carbonic anhydrase III.

Carbonic anhydrase III.

Journal: The Enzymes

Published: July 22, 2026

Discovery of Subnanomolar and Highly Selective Carbonic Anhydrase II Inhibitors Featuring L-Shaped Scaffolds via Active-Site-Matched Fragment Growing.

Discovery of Subnanomolar and Highly Selective Carbonic Anhydrase II Inhibitors Featuring L-Shaped Scaffolds via Active-Site-Matched Fragment Growing.

Journal: Journal of medicinal chemistry

Published: June 15, 2026

Structure-Activity Relationship Studies for 1,3,4-Thiadiazole-Based Bacterial Carbonic Anhydrase Inhibitors with In Vivo Efficacy against Drug-Resistant Neisseria gonorrhoeae.

Structure-Activity Relationship Studies for 1,3,4-Thiadiazole-Based Bacterial Carbonic Anhydrase Inhibitors with In Vivo Efficacy against Drug-Resistant Neisseria gonorrhoeae.

Journal: Journal of medicinal chemistry

Published: May 06, 2026

Mechanisms of Carbonic Anhydrase Catalysis and Inhibition.

Mechanisms of Carbonic Anhydrase Catalysis and Inhibition.

Journal: Sub-cellular biochemistry

Published: April 30, 2026

Applications of Carbonic Anhydrase Inhibitors in Arthritis, Neuropathic Pain, Acute Mountain Sickness, and Cerebral Ischemia.

Applications of Carbonic Anhydrase Inhibitors in Arthritis, Neuropathic Pain, Acute Mountain Sickness, and Cerebral Ischemia.

Journal: Sub-cellular biochemistry

Published: April 30, 2026

Design and Synthesis of Bis-Triazole-Linked Benzenesulfonamides as Selective Carbonic Anhydrase IX/XII Inhibitors with Chemosensitizing Activity.

Design and Synthesis of Bis-Triazole-Linked Benzenesulfonamides as Selective Carbonic Anhydrase IX/XII Inhibitors with Chemosensitizing Activity.

Journal: Journal of medicinal chemistry

Published: April 30, 2026

Therapeutic Applications of Carbonic Anhydrase Inhibitors in Ophthalmology.

Therapeutic Applications of Carbonic Anhydrase Inhibitors in Ophthalmology.

Journal: Sub-cellular biochemistry

Published: April 30, 2026

Discovery of a Mixed and Prodrug-Like Inhibition Mechanism for Phosphocoumarins and Phosphoquinolinones against Human Carbonic Anhydrases.

Discovery of a Mixed and Prodrug-Like Inhibition Mechanism for Phosphocoumarins and Phosphoquinolinones against Human Carbonic Anhydrases.

Journal: Journal of medicinal chemistry

Published: April 29, 2026

Identification of Sulfonamide-Based Thiazolidine-2,4-Dione Derivatives as VEGFR-2 and Tumor-Associated hCA IX Inhibitors With Hypoxia-Targeted Anti-Colorectal Cancer Activity.

Identification of Sulfonamide-Based Thiazolidine-2,4-Dione Derivatives as VEGFR-2 and Tumor-Associated hCA IX Inhibitors With Hypoxia-Targeted Anti-Colorectal Cancer Activity.

Journal: Drug development research

Published: April 08, 2026

Coumarin-Thiourea Hybrids: Structural Features Governing CA Inhibition and Antiproliferative Effects.

Coumarin-Thiourea Hybrids: Structural Features Governing CA Inhibition and Antiproliferative Effects.

Journal: International journal of molecular sciences

Published: February 21, 2026

First-in-Class Dual PDGFR/Carbonic Anhydrase IX/XII Inhibitors: 6,7-Dimethoxyquinoline-Sulfonamides as Promising Antileukemic Agents.

First-in-Class Dual PDGFR/Carbonic Anhydrase IX/XII Inhibitors: 6,7-Dimethoxyquinoline-Sulfonamides as Promising Antileukemic Agents.

Journal: Journal of medicinal chemistry

Published: January 26, 2026

Multi-target pyrazolopyrimidine-coumarin derivatives as potent CA IX/XII and tubulin polymerization inhibitors: Design, synthesis, and biological evaluation.

Multi-target pyrazolopyrimidine-coumarin derivatives as potent CA IX/XII and tubulin polymerization inhibitors: Design, synthesis, and biological evaluation.

Journal: European journal of medicinal chemistry

Published: January 21, 2026

Showing 1-12 of 291

Last Updated: 09/26/2026